Abzena has augmented existing 500 L scale biologics equipment with a $20 million investment into two new manufacturing suites at 500 L and 2000 L scale in a new GMP facility in San Diego, CA which will be equipped with Sartorius single use bioreactors. Abzena’s existing expertise in cell line development is strengthened with a new ambr 15 automated high throughput bioreactor in Cambridge, UK, and existing synthetic chemistry capacity is increased with build out of a fully equipped multi-fume hoo...